Bucshon, DeGette Release Statement on Burdensome FDA Rule Regulating Lab-Developed Tests
April 30, 2024
April 30, 2024
WASHINGTON, April 30 -- Rep. Larry Bucshon, R-Indiana, issued the following statement on April 29, 2024:
* * *
Today, Congressman Larry Bucshon, M.D. (IN-08) and Congresswoman Diana DeGette (CO-01) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs).
"Rational oversight of in-vitro diagnostics, including laboratory-developed tes . . .
* * *
Today, Congressman Larry Bucshon, M.D. (IN-08) and Congresswoman Diana DeGette (CO-01) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs).
"Rational oversight of in-vitro diagnostics, including laboratory-developed tes . . .